The Standard Care vs. COrticosteroid for REtinal Vein Occlusion Study

Welcome to the Standard Care vs. Corticosteroid for Retinal Vein Occlusion (SCORE) Study home page.

The SCORE Study was a multi-center, randomized Phase III trial designed to assess the efficacy and safety of standard care versus triamcinolone acetonide injection(s) for the treatment of macular edema associated with central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). The study was completed in February 2009. For more information about the SCORE Study, email the SCORE Coordinating Center at or call 301-251-1161.

The SCORE Study was sponsored by the National Eye Institute, National Institutes of Health, Department of Health and Human Services in Bethesda, Maryland.

Click here for link to the SCORE Study on the website.

SCORE Study Information: SCORE Study Publications:
SCORE Study Protocol Synopsis Publication Policies
Inclusion/Exclusion Criteria Publication Proposal Form
SCORE Study Clinical Sites SCORE Study Primary Results Presentation